What does this research mean for the field?

Apolipoproteins CIII and AV are key modulators of triglyceride metabolism and potential therapeutic targets for hypertriglyceridemia, though their specific molecular mechanisms and potential synergistic cooperativity require further investigation. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

May 11, 2004Current Opinion in Lipidology

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

View Full Paper

Ask AI

Bookmark

Design

Review

Authors

KDKo Willems van DijkLeiden University Medical Center PRPatrick C.N. RensenLeiden University Medical Center PVPeter J. VosholGoethe University Frankfurt

Discussion

Member takes

Implication

Supports APOC3/APOA5 as triglyceride targets in hypertriglyceridemia; leaves open mechanisms and cooperativity for clinical translation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dijk et al. (2004) studied this question.

synapsesocial.com/papers/6a19acc33f3ec013f0dee87e https://doi.org/10.1097/00041433-200406000-00002

View Full Paper

Ask AI

Bookmark

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

Discussion

Member takes

Implication

Key Points

Cite This Study

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider